{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:48:47Z","timestamp":1788922127622,"version":"build-2803163510"},"reference-count":113,"publisher":"Informa UK Limited","issue":"1","funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA051709"],"award-info":[{"award-number":["K01DA051709"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Commonwealth of Pennsylvania CURE Project","award":["SAP#4100055577"],"award-info":[{"award-number":["SAP#4100055577"]}]},{"name":"Center for Pain and the Brain Harvard Medical School"},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The David Borsook Project"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Addictive Diseases"],"published-print":{"date-parts":[[2025,1,2]]},"DOI":"10.1080\/10550887.2024.2327739","type":"journal-article","created":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T23:08:59Z","timestamp":1711926539000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity"],"prefix":"10.1080","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5697-2034","authenticated-orcid":false,"given":"Zhenhao","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Center for Studies of Addiction, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"D. Langleben","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Center for Studies of Addiction, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rott","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sheba Medical Center, Sackler School of Medicine, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Albanese","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Cambridge Health Alliance, Harvard Medical School, Boston, MA, USA"},{"name":"Physician Health Services, Massachusetts Medical Society, Waltham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Elman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Cambridge Health Alliance, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,3,31]]},"reference":[{"key":"e_1_3_3_2_1","volume-title":"Medication-assisted treatment for opioid addiction in opioid treatment programs","author":"Center for Substance Abuse Treatment","year":"2005","unstructured":"Center for Substance Abuse Treatment. Medication-assisted treatment for opioid addiction in opioid treatment programs. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2005."},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201300235"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201300256"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcrp.2021.200123"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.002"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaa006"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301051"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62556-0"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112450783"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/XCE.0000000000000263"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113509904"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2022.01.003"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.01.039"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2503-1"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200512000-00008"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0244-2"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12915"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1973.03220060039009"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0376-8716(00)00139-3"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002024.pub5"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102218"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-2-30"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(93)90544-4"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008506-199907000-00007"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2016.07.008"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02102950"},{"key":"e_1_3_3_28_1","unstructured":"www.webmd.com. Naltrexone HCL side effects by likelihood and severity; 2023. https:\/\/www.webmd.com\/drugs\/2\/drug-7399\/naltrexone-oral\/details\/list-sideeffects."},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00241-X"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02317.x"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/emj.20.4.381"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-198801000-00002"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpsycho.2008.03.005"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.1993.54.235"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152710790966704"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.psy.0000116250.81254.5d"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsycho.2007.10.005"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2018.12.005"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(77)90462-0"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.919773"},{"key":"e_1_3_3_41_1","volume-title":"Morphine","author":"Murphy PB","year":"2023","unstructured":"Murphy PB, Bechmann S, Barrett MJ. Morphine. Treasure Island (FL): StatPearls; 2023."},{"key":"e_1_3_3_42_1","volume-title":"Opioid overdose","author":"Schiller EY","year":"2023","unstructured":"Schiller EY, Goyal A, Mechanic OJ. Opioid overdose. Treasure Island (FL): StatPearls; 2023."},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200207001-00002"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18010223"},{"issue":"2","key":"e_1_3_3_45_1","first-page":"273","article-title":"Involvement of the renin-angiotensin system in the dipsogenic effect of morphine","volume":"278","author":"Lal J","year":"1985","unstructured":"Lal J, Atkinson J. Involvement of the renin-angiotensin system in the dipsogenic effect of morphine. Arch Int Pharmacodyn Ther. 1985;278(2):273\u201391.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2016-0111"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2014.05.002"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.11m01326"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.7789"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021260"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyt080"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-014-0131-y"},{"key":"e_1_3_3_53_1","unstructured":"National Institute on Drug Abuse. Heroin DrugFacts; 2023. https:\/\/nida.nih.gov\/publications\/drugfacts\/heroin."},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349"},{"issue":"20","key":"e_1_3_3_55_1","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan DV","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22\u201333; quiz 34\u201357.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyz002"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2021.102806"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.22br14567"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.170036"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(92)90062-s"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"e_1_3_3_62_1","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Guy W.","year":"1976","unstructured":"Guy W. ECDEU assessment manual for psychopharmacology. Washington (DC): U.S. Department of Health, Education, and Welfare; 1976."},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.9.6.561"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1994.tb00898.x"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042098617744161"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1159\/000492616"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.873169"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-020-07132-4"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1177\/1535370213492688"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-013-9204-4"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.2c00079"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.02.008"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06738-3"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1998.80.1.1"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1974161part151"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.128386"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L168"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12475"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.28.061604.135722"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2016.05.033"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2015.11.027"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.174"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2013.06.003"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.581989"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2019.04.023"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.13.6.808"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)60492-8"},{"issue":"2","key":"e_1_3_3_88_1","first-page":"190","article-title":"Sympathetic activation in cardiovascular and renal disease","volume":"22","author":"Grassi G","year":"2009","unstructured":"Grassi G, Arenare F, Pieruzzi F, Brambilla G, Mancia G. Sympathetic activation in cardiovascular and renal disease. J Nephrol. 2009;22(2):190\u20135.","journal-title":"J Nephrol"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.140186"},{"key":"e_1_3_3_90_1","volume-title":"Physiology, peripheral vascular resistance","author":"Delong C","year":"2023","unstructured":"Delong C, Sharma S. Physiology, peripheral vascular resistance. Treasure Island (FL): StatPearls; 2023."},{"key":"e_1_3_3_91_1","volume-title":"Physiology, cardiovascular","author":"Chaudhry R","year":"2023","unstructured":"Chaudhry R, Miao JH, Rehman A. Physiology, cardiovascular. Treasure Island (FL): StatPearls; 2023."},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302524"},{"key":"e_1_3_3_93_1","volume-title":"Physiology, cardiac output","author":"King J","year":"2023","unstructured":"King J, Lowery DR. Physiology, cardiac output. Treasure Island (FL): StatPearls; 2023."},{"key":"e_1_3_3_94_1","volume-title":"Physiology, afterload reduction","author":"LaCombe P","year":"2023","unstructured":"LaCombe P, Tariq MA, Lappin SL. Physiology, afterload reduction. Treasure Island (FL): StatPearls; 2023."},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.26.3.377"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012954"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.5931"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.810105"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.3317\/jraas.2007.030"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(85)90372-9"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03226-7"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.1652"},{"key":"e_1_3_3_103_1","first-page":"25","article-title":"Insulin and the sympathetic nervous system in the pathophysiology of hypertension","volume":"1","author":"Landsberg L.","year":"1996","unstructured":"Landsberg L. Insulin and the sympathetic nervous system in the pathophysiology of hypertension. Blood Press Suppl. 1996;1:25\u20139.","journal-title":"Blood Press Suppl"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199300462-00024"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i13.3008"},{"key":"e_1_3_3_106_1","unstructured":"National Quality Forum. Continuity of pharmacotherapy for opioid use disorder (OUD) \u2013 national quality strategy domain: effective clinical care \u2013 meaningful measure area: prevention and treatment of opioid and substance use disorders; 2019. https:\/\/qpp.cms.gov\/docs\/QPP_quality_measure_specifications\/CQM-Measures\/2019_Measure_468_MIPSCQM.pdf."},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12060782"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291711000717"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1247961"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.3206"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.11363"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00569"}],"container-title":["Journal of Addictive Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10550887.2024.2327739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:44:40Z","timestamp":1735519480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10550887.2024.2327739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,31]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,2]]}},"alternative-id":["10.1080\/10550887.2024.2327739"],"URL":"https:\/\/doi.org\/10.1080\/10550887.2024.2327739","relation":{},"ISSN":["1055-0887","1545-0848"],"issn-type":[{"value":"1055-0887","type":"print"},{"value":"1545-0848","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=wjad20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=wjad20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-03-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}